Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Alves

Showing results (81-90 of 111) with videos related to

Pageof 12
Sort By:
Neuro-Oncology Practice|March 9, 2026
Cognitive function in long-term survivors after treatment for brain metastases compared with normative samplesGuro Lindviksmoen Astrup, Monica Kløvstad Siksjø, Nina Aass, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 11, 2026
Prognosis in Parkinson's Disease: An Individual Patient Data Meta-Analysis of Six European Incidence CohortsAngus D Macleod, David J McLernon, Marta Camacho, et al.
Journal of Neurology|November 20, 2021
Neurofilament light in plasma is a potential biomarker of central nervous system involvement in systemic lupus erythematosusMaria Boge Lauvsnes, Henrik Zetterberg, Kaj Blennow, et al.
Parkinsonism & Related Disorders|April 21, 2019
Combinatory microRNA serum signatures as classifiers of Parkinson's diseaseKetan S Patil, Indranil Basak, Ingvild Dalen, et al.
Parkinsonism & Related Disorders|June 23, 2026
Personalised prediction of institutionalisation in Parkinson's: prognostic factor identification and model development and validation using IPD meta-analysisYan Li, David J McLernon, Rachael A Lawson, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 3, 2012
Cerebrospinal fluid amyloid-β and phenotypic heterogeneity in de novo Parkinson's diseaseGuido Alves, Kenn Freddy Pedersen, Bastiaan R Bloem, et al.
NPJ Parkinson'S Disease|July 3, 2025
Beta-adrenoceptor drugs and progression to Parkinson's disease milestones in a large pooled incident cohortRuwani S Wijeyekoon, Marta Camacho, David Bäckström, et al.
Neurology. Genetics|August 18, 2020
Genetic risk scores and hallucinations in patients with Parkinson diseaseCynthia D J Kusters, Kimberly C Paul, Aline Duarte Folle, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 15, 2013
Cerebrospinal fluid Aβ levels correlate with structural brain changes in Parkinson's diseaseMona K Beyer, Guido Alves, Kristy S Hwang, et al.
Journal of Neurology|October 31, 2020
Neurofilament light is a biomarker of brain involvement in lupus and primary Sjögren's syndromeAnne B Tjensvoll, Maria B Lauvsnes, Henrik Zetterberg, et al.
Pageof 12

Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
Neuro-Oncology Practice|March 9, 2026
Cognitive function in long-term survivors after treatment for brain metastases compared with normative samplesGuro Lindviksmoen Astrup, Monica Kløvstad Siksjø, Nina Aass, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 11, 2026
Prognosis in Parkinson's Disease: An Individual Patient Data Meta-Analysis of Six European Incidence CohortsAngus D Macleod, David J McLernon, Marta Camacho, et al.
Journal of Neurology|November 20, 2021
Neurofilament light in plasma is a potential biomarker of central nervous system involvement in systemic lupus erythematosusMaria Boge Lauvsnes, Henrik Zetterberg, Kaj Blennow, et al.
Parkinsonism & Related Disorders|April 21, 2019
Combinatory microRNA serum signatures as classifiers of Parkinson's diseaseKetan S Patil, Indranil Basak, Ingvild Dalen, et al.
Parkinsonism & Related Disorders|June 23, 2026
Personalised prediction of institutionalisation in Parkinson's: prognostic factor identification and model development and validation using IPD meta-analysisYan Li, David J McLernon, Rachael A Lawson, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 3, 2012
Cerebrospinal fluid amyloid-β and phenotypic heterogeneity in de novo Parkinson's diseaseGuido Alves, Kenn Freddy Pedersen, Bastiaan R Bloem, et al.
NPJ Parkinson'S Disease|July 3, 2025
Beta-adrenoceptor drugs and progression to Parkinson's disease milestones in a large pooled incident cohortRuwani S Wijeyekoon, Marta Camacho, David Bäckström, et al.
Neurology. Genetics|August 18, 2020
Genetic risk scores and hallucinations in patients with Parkinson diseaseCynthia D J Kusters, Kimberly C Paul, Aline Duarte Folle, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 15, 2013
Cerebrospinal fluid Aβ levels correlate with structural brain changes in Parkinson's diseaseMona K Beyer, Guido Alves, Kristy S Hwang, et al.
Journal of Neurology|October 31, 2020
Neurofilament light is a biomarker of brain involvement in lupus and primary Sjögren's syndromeAnne B Tjensvoll, Maria B Lauvsnes, Henrik Zetterberg, et al.
Pageof 12